iShares Russell 1000 ETF (the Fund), formerly iShares Russell 1000 Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the Russell 1000 Index (the Index). The Index is a float-adjusted capitalization weighted index that measures the performance of the large-capitalization sector of the United States equity market and includes securities issued by the approximately 1,000 largest issuers in the Russell 3000 Index. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Index is a subset of the Russell 3000 Index and serves as the underlying index for the Russell 1000 Growth and Value Indices, and the Russell Top 200 and MidCap series. BlackRock Fund Advisors (BFA) serves as the investment adviser to the Fund.
Basic Details
Issuer iShares
Fund NameiShares Russell 1000 ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:IWB
Inception Date5/15/2000
Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
Phone+1-800-4742737
Fund Focus
Asset ClassEquity
BenchmarkRussell 1000 Index
CategorySize and Style
FocusLarge Cap
Development LevelDeveloped Markets
RegionNorth America
Fund Statistics
Assets Under Management$22.75 billion
Average Daily Volume$861,746.30
Discount/Premium-0.11%
ETF Expenses
Management Fee0.15%
Other Expenses0.00%
Total Expenses0.15%
Fee Waiver0.00%
Net Expenses0.15%
Administrator, Advisor and Custodian
AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerLatour Trading
(Ad)
If you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval.
